Medical Advisory Board

Medical Advisory Board

NYSCF's Medical Advisory Board comprises an internationally renowned roster of scientists, researchers and heads of the Northeast's pre-eminent medical institutions. We are privileged to count among our MAB Board, both Nobel Laureates and the leading stem cell researchers in the country. NYSCF's MAB members advise the Foundation on a range of issues, including priorities for NYSCF's safe haven labs and the awarding of grants to scientists doing translational stem cell research within their own facilities.

Asa Abeliovich, MD, PhD

Assistant Professor, Pathology, Cell Biology and Neurology, the Taub Institute for Aging, Columbia University.

Ali H. Brivanlou, PhD

Professor and Head of Laboratory, Laboratory of Molecular Embryology at The Rockefeller University.

Moses V. Chao, PhD

Professor of Cell Biology, Physiology and Neuroscience at NYU School of Medicine. Dr. Chao is also the Co-Coordinator of the Molecular Neurobiology Program at Skirball Institute of Biomolecular Medicine.

Dennis S. Charney, MD

Anne and Joel Ehrenkranz Dean, Mount Sinai School of Medicine. Dr. Charney is also Executive Vice President for Academic Affairs at The Mount Sinai Medical Center and Professor in the Departments of Psychiatry, Neuroscience, and Pharmacology & Systems Therapeutics at Mount Sinai School of Medicine.

Chi Van Dang, MD, PhD

Dr. Dang serves as director of Penn’s Abramson Cancer Center and director of the Abramson Family Cancer Research Institute for Penn Medicine.

Valina Dawson, PhD

Professor and Vice-Chair in the Departments of Neurology, Neuroscience, Physiology and Cell and Molecular Medicine at The Johns Hopkins University School of Medicine. Dr. Dawson is also Director of Neurobiology of Disease in the Department of Neurology, and Director of Neuroregeneration and Stem Cell Programs in the Institute for Cell Engineering at Johns Hopkins.

Kevin Eggan, PhD*

Assistant  Professor  of  Stem  Cell  and  Regenerative  Biology  at  Harvard  University. Dr. Eggan is currently leading a research group investigating mechanisms regulating epigenetic reprogramming after SCNT and using nuclear transfer techniques to derive disease specific stem cell lines from diabetic and Parkinson's patients. Dr. Eggan was a 2006 MacArthur Fellow.

Gerald D. Fischbach, MD

Scientific Director of the Simons Foundation Autism Project. Dr. Fischbach is also Dean of the Faculty of Health Sciences and Medicine, Emeritus, and John E. Borne Professor, at Columbia University.

Gordon Fishell, PhD

Professor of Cell Biology at NYU Medical Center.

Paul S. Frenette, MD

Director of the Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research at Albert Einstein College of Medicine. Dr. Frenette is also a Professor in the Departments of Medicine and Cell Biology.

Elaine Fuchs, PhD

Rebecca C. Lancefield Professor of Mammalian Cell Biology & Development, The Rockefeller University. Dr. Fuchs is also an Investigator at the Howard Hughes Medical Institute.

John D. Gearhart, PhD

Director of the Institute for Regenerative Medicine at the University of Pennsylvania and a Penn Inegrates Knowledge Professor.   Dr. Gearhart is also the James W. Effron University Professor at Penn.

Laurie H. Glimcher, MD

Cornell University provost for medical affairs and the Stephen and Suzanne Weiss Dean at Weill Cornell Medical College. Previously, she was the Irene Heinz Given Professor of Immunology at the Harvard School of Public Health and Professor of Medicine at Harvard Medical School.

Robin Goland, MD

Founder and co-director of the Naomi Berrie Diabetes Center at Columbia University Medical Center. An Associate Professor of Medicine at Columbia, Dr. Goland also leads a clinical research program in diabetes.

Lee Goldman, MD, MPH

Executive Vice President for Health and Biomedical Sciences, Dean of the Faculties of Health Sciences and Medicine at the College of Physicians and Surgeons of Columbia University. A member of the American Society for Clinical Investigation, Dr. Goldman is also President of the Association of Professors of Medicine and a member of the Institute of Medicine of the National Academy of Sciences.

Steven Goldman, MD, PhD

Edward A. and Alma Vollertsen Rykenboer Chair in Neurophysiology and Professor of Neurology and Neurosurgery at the University of Rochester Medical Center.

James Grifo, MD, PhD

Director, Division of Reproductive Endocrinology and Professor, Obstetrics and Gynecology, NYU School of Medicine. Attending Physician, Department of Obstetrics and Gynecology, Tisch Hospital.

Zach Hall, PhD*

Former President, The California Institute of Regenerative Medicine and former Director, National Institute of Neurological Disorders and Stroke. Dr. Hall is also a NYSCF Board Member.

Thomas M. Jessell, PhD

Investigator of the Howard Hughes Medical Institute and Professor of Biochemistry and Molecular Biophysics at Columbia University College of Physicians and Surgeons. Dr. Jessell's lab examines how neurons in the vertebrate central nervous system (CNS) are generated and interconnected, focusing on circuits formed between sensory and motor neurons in the spinal cord.

Robert S. Kass, PhD

Chairman in the Department of Pharmacology and Hosack Professor of Pharmacology at Columbia University.

Gordon Keller, PhD

Director of the McEwan Center for Regerative Medicine University Health Network, Toronto, Canada.

Ruth Lehmann, PhD

Investigator of the Howard Hughes Medical Institute and Director of the Helen and Martin Kimmel Center for Stem Cell Biology at NYU School of Medicine. Dr. Lehmann, a fellow of the American Academy of Arts and Sciences and a member of the National Academy of Science, is Professor of Developmental Genetics at NYU School of Medicine.

Rudolph Leibel, MD*

Co-Director of the Naomi Berrie Diabetes Center at Columbia University, a Professor of Pediatrics and Medicine and head of the Division of Molecular Genetics at Columbia University College of Physicians and Surgeons. Dr. Leibel is also Deputy Director of the New York Obesity Research Center.

Ihor Lemischka, PhD

Professor of Gene and Cell Medicine at The Mount Sinai School of Medicine.

Haifan Lin, PhD

Professor of Cell Biology and Director of the Yale Stem Cell Center at the Yale School of Medicine.

Dan R. Littman, MD, PhD

Investigator of the Howard Hughes Medical Institute and the Helen L. and Martin S. Kimmel Professor of Molecular Immunology and Professor of Pathology and Microbiology at the NYU School of Medicine. Dr. Littman directs the Molecular Pathogenesis program in the Skirball Institute of Biomolecular Medicine at the NYU Medical Center.

Douglas A. Melton, PhD*

Investigator of the Howard Hughes Medical Institute, Co-Chairman of the Department of of Stem Cell and Regenerative Biology at Harvard University, the Thomas Dudley Cabot Professor in the Natural Sciences at Harvard, and Co-Director of the Harvard Stem Cell Institute. Dr. Melton received the Lounsberry Medal from the National Academy of Sciences and the Joslin Medal in 2003.

Christine Mummery, PhD

Professor, Developmental Biology and Chair, Department of Anatomy and Embryology at Leiden University Medical Center. She is also elected member of the board of ISSCR, president elect of the International Society of Differentiation, and a member of Royal Netherlands Academy of Arts and Sciences.

Mark Noble, PhD

Professor of Genetics, Neurobiology and Anatomy at University of Rochester Medical Center and co-director of the New York Center of Research Excellence in Spinal Cord Injury.   Dr. Noble's laboratory works broadly in the field of stem cell research and stem cell medicine, including such areas as cell discovery, signaling pathway dissection, oxidative regulation, developmental maladies, toxicology and cancer research.

Paul Nurse, PhD

President of The Royal Society and Former President of The Rockefeller University. Dr. Nurse won the Nobel Prize in Physiology or Medicine in 2001 for his work characterizing the cell cycle in yeast. He also received the Lasker Award in 1998 and the General Motors Cancer Research Foundation Alfred P. Sloan Jr. Prize and Medal in 1997.

Herbert Pardes, MD

President and CEO of New York-Presbyterian Hospital. Dr. Pardes has also been Vice-President for Health Sciences and Dean of the Faculty of Medicine at the College of Physicians and Surgeons of Columbia University.   Dr. Pardes served as Director of the National Institute of Mental Health (NIMH) and as U.S. Assistant Surgeon General during the Carter and Reagan Administrations.

Shahin Rafii, MD

Investigator of the Howard Hughes Medical Institute and Director of the Ansary Stem Cell Center for Regenerative Medicine at Weill Medical College of Cornell University. Dr. Rafii is also the Arthur Belfer Professor of Genetic Medicine at Weill Medical College of Cornell.

Mahendra Rao, PhD

Director-NIH Center for Regenerative Medicine at National Institutes of Health. Most recently, Dr. Rao spent six years as the Vice President of Regenerative Medicine at Life Technologies in Carlsbad, California. He co-founded Q Therapeutics, a neural stem cell company based in Salt Lake City, Utah.

Lee Rubin, PhD*

Director of Translational Medicine at the Harvard University Stem Cell Institute. Dr. Rubin is also a NYSCF Scientific Advisor.

Allen M. Spiegel, MD

Marilyn and Stanley M. Katz Dean of the Albert Einstein College of Medicine of Yeshiva University. Dr. Spiegel is a widely renowned physician-scientist and endocrinologist with extensive experience in translational research who previously served as the Director of the National Institute of Diabetes and Digestive and Kidney Diseases at the National Institutes of Health.

Lorenz Studer, MD

Associate Member of the Developmental Biology Program and Division of Neurosurgery at Memorial Sloan-Kettering Cancer Center.

Sally Temple, PhD

Scientific Director of the New York Neural Stem Cell Institute and Professor of Neuropharmacology and Neuroscience at Albany Medical College. Dr. Temple was also a 2008 MacArthur Fellow.

Marc Tessier-Lavigne, PhD

President of The Rockefeller University. Formerly Executive Vice President for Research and Chief Scientific Officer at Genentech.

Craig B. Thompson, MD

President and Chief Executive Officer of Memorial Sloan-Kettering Cancer Center.

Harold Varmus, MD (Emeritus)

Director of the National Cancer Institute and Co-Chair of the President's Council of Advisors on Science and Technology. Formerly President and Chief Executive Officer of Memorial Sloan Kettering Cancer Center. Dr.Varmus received the Nobel Prize in Physiology or Medicine in 1989 for his studies of the genetic basis of cancer. From 1983 to 1999, Dr. Varmus served as Director of the National Institutes of Health.

Gordana Vunjak-Novakovic, PhD

Professor of Biomedical Engineering at Columbia University.

Irving Weissman, MD

Director, Stanford Institute for Stem Cell Biology and Regenerative Medicine. Dr. Weissman is also the Direcor of the Ludwig Center at Stanford Universtiy and Professor of Pathology and Developmental Biology.
* Member, NYSCF Medical Advisory Board Executive Committee
You are here: About Us Boards & Councils Medical Advisory Board